“The upcoming target groups for vaccination are less likely to become severely ill from Covid-19,” he said. “We must weigh this against the fact that we now have a known risk of severe adverse effects from vaccination with AstraZeneca, even if the risk in absolute terms is slight.”
Click Here to Visit Orignal Source of Article https://www.bbc.co.uk/news/world-europe-56744474
